SCHEMBL5372976

SCHEMBL5372976

CSc1nsc(OCc2ccccc2C(F)(F)F)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.43
MAOB P27338 4/20 0.42
MAOA P21397 1/20 0.42
HCAR2 Q8TDS4 1/20 0.38
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
PLK1 P53350 3/20 0.35
SGMS2 Q8NHU3 1/20 0.34
F2RL3 Q96RI0 1/20 0.34
SLC6A4 P31645 1/20 0.34
ALOX5 P09917 1/20 0.34
ALOX5AP P20292 1/20 0.34
IKBKE Q14164 1/20 0.34
F2 P00734 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373443 0.80 MAPT (0.41) IDO1MAOBMAOAF2RL3TDP1
SCHEMBL5373469 0.76 MAOB (0.41) IDO1MAOBF2RL3MAPK1TDP1
SCHEMBL5378135 0.75 MAOB (0.46) IDO1MAOBMAOAHCAR2FFAR1
SCHEMBL5375933 0.72 RAB9A (0.38) MAPK1TDP1ALDH1A1LMNATSHR
SCHEMBL5377692 0.72 MAPK1 (0.39) SLC6A4ALOX5MAPK1TDP1ALDH1A1
SCHEMBL5636919 0.72 MAPK1 (0.39) SLC6A4ALOX5MAPK1TDP1ALDH1A1
SCHEMBL5378771 0.71 TDP1 (0.56) IDO1MAOBMAPK1TDP1ALDH1A1
SCHEMBL4799608 0.70 SMN1; SMN2 (0.42) MAPK1TDP1ALDH1A1LMNATSHR
SCHEMBL5398094 0.70 MAPT (0.46) IDO1MAPK1TDP1ALDH1A1LMNA
SCHEMBL5398160 0.70 MEN1 (0.39) F2RL3MAPK1TDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-20050215578-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-09-29 US disclosed
EP-1475374-A1 THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215578-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH IDO1 890/4885MAOB 641/4885MAOA 1727/4885
US-20070293510-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH IDO1 912/4885MAOB 700/4885MAOA 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.